Zura Bio (ZURA) Enters $112.5M Private Placement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Zura Bio (ZURA) Enters $112.5M Private Placement

Zura Bio Announces Oversubscribed $112.5 Million Private Placement

April 18, 2024 9:22 AM EDT

- Financing includes new and existing leading life sciences institutional investors

- Strengthened balance sheet expected to fund operations through 2027

HENDERSON, Nev.--(BUSINESS WIRE)-- Zura Bio Limited (Nasdaq: ZURA) (Zura Bio), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced that it has entered into subscription agreements for a private placement that is expected to result in gross proceeds of approximately $112.5 million, before deducting placement agent fees and offering expenses (the Private Placement).

The Private Placement is led by Access Biotechnology and a... More